Evidence map›Paper›PMID 27942358›Full record

ArticleJundishapur journal of microbiology2016

NDM-1 and rmtC-Producing

Tulin Guven Gokmen, Togrul Nagiyev, Melda Meral, Cansu Onlen, Farzad Heydari, Fatih Koksal

Abstract read
In one paragraph

Article in Jundishapur journal of microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Characterization of Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  4. Article
  5. The Characteristic of Virulence, Biofilm and Antibiotic Resistance ofInternational journal of environmental research and public health · 2020
    Review
  6. Article
  7. Coexistence ofInfection and drug resistance · 2019
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tulin Guven GokmenDepartment of Microbiology, Ceyhan Veterinary Faculty, Cukurova University, Adana, Turkey.
Togrul NagiyevDepartment of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Melda MeralDepartment of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Cansu OnlenDepartment of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Farzad HeydariDepartment of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Fatih KoksalDepartment of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe resistance of aminoglycosides in strains that produce beta-lactamase can be developed through the multidrug resistant encoding genes carried by common plasmids. Recently, the association between 16S rRNA methyltransferase resistance and beta-lactamase enzymes carried by the same plasmids has drawn increased attention from researchers, particularly the association in aminoglycoside-resistant strains with a minimum inhibitory concentration (MIC) of ≥ 256 µg/mL.

objectivesWe aimed to investigate the co-existence of 16S rRNA methyltransferase and beta-lactamase genes in multidrug resistant (MDR)

methodsWe determined the molecular mechanisms of aminoglycoside resistance and its relationship with resistance to carbapenem and beta-lactam group antibiotics in 40 extended-spectrum beta-lactamase (ESBL)-positive carbapenem- and aminoglycoside-resistant

resultsTwenty

conclusionsThis study demonstrated the co-existence of

Indexed as

16S rRNA -m7G methyltransferaseBeta-Lactamase NDM-1Klebsiella pneumoniaeRmtC

Identifiers

PMID27942358
PMCPMC5136449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.